NEXGEL, INC. current report, 07 October 2026

NEXGEL, Inc. — Form 8-K Summary

Filed: October 7, 2026. This current report concerns a corporate action, not a financial-results reporting period.

Business context and material event

After stockholders approved authority for a reverse stock split on September 23, 2026, the Board selected a 1-for-20 split. The Company filed the related Certificate of Amendment with Delaware on October 7, 2026. The split is scheduled to take effect at 12:01 a.m. Eastern Time on October 12, 2026.

Effect on securities

  • Each 20 shares of issued and outstanding common stock will automatically become one share.
  • Fractional shares will be rounded up to one whole share; no cash will be paid in lieu of fractional shares.
  • Outstanding equity awards, convertible preferred stock, warrants, and other convertible or exercisable securities, along with their applicable prices, will be adjusted proportionally under their terms.
  • Common-stock par value remains $0.001 per share, and the number of authorized shares of capital stock will not change.
  • Common stock is expected to remain listed on the Nasdaq Capital Market under ticker NXGL, with new CUSIP 65344E 206.

The filing identifies the split as a material modification to security holders’ rights. It provides no revenue, earnings, cash-flow, margin, debt, liquidity, or other operating financial metrics, and no guidance or outlook.

Important facts for investors to verify

  • Confirm the October 12, 2026 effective time and the processing of the 1-for-20 split with the Company or broker.
  • Review the Certificate of Amendment and the terms governing adjustments to warrants, preferred stock, and other securities.
  • Verify post-split share balances, fractional-share rounding, and the new CUSIP with the transfer agent or broker.
  • Monitor Nasdaq listing and trading arrangements following the split.